PCA(P)(2026)18 - SSPs for Estradot® and Creon® Extended

Publsihed: 5th October 2026

Serious Shortage Protocols (SSPs) covering selected Estradot® transdermal patches and Creon® gastro-resistant capsules have been extended until 8th January 2027. Community pharmacy teams may wish to review the revised expiry date and ensure they remain familiar with the requirements of the existing protocols. Click the button below to donwload the SG Circular.

---

Frequently Asked Questions (FAQs)

• When do the SSPs for Estradot® and Creon® now expire?

  The four SSPs covering Estradot® transdermal patches and the two SSPs covering Creon® gastro-resistant capsules have been extended until Friday, 8th January 2027.

  Source: Scottish Government

• Which Estradot® SSPs have been extended?

  The extension applies to SSP079 (Estradot® 50 mcg), SSP080 (Estradot® 75 mcg), SSP081 (Estradot® 100 mcg) and SSP082 (Estradot® 25 mcg).

  Source: Scottish Government

• What does the Estradot® Serious Shortage Protocol allow pharmacists to do?

  The SSPs allow community pharmacists to substitute eligible prescriptions for specified Estradot® patches with the equivalent strength and quantity of Evorel® or Estraderm MX® transdermal patches in accordance with the relevant SSP requirements.

  Source: Scottish Government

• What does the Creon® SSP allow pharmacists to supply?

  The Creon® SSPs allow community pharmacists to restrict the total quantity supplied to one month's supply of the prescribed medicine.

  Source: Scottish Government